Simple Summary Glioblastoma multiforme (GBM) is one of the most aggressive
malignancies, accounting for 14.5% of all central nervous system tumors and 48.6% of …

Glioblastoma (GBM) is the most aggressive malignant primary brain tumor. With an
incidence rate of 3.19 per 100,000 persons in the United States and a median age of 64 …

Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …

Sex differences have been well identified in many brain tumors. Even though glioblastoma
(GBM) is the most common primary malignant brain tumor in adults and has the worst …

Materials and Methods All histological diagnoses of GBM in Malta from 2008 to 2017 were
identified. Poisson regression was used to determine significance in incidence variation …

Background Primary brain tumors are a heterogeneous group of benign and malignant
tumors arising from the brain parenchyma and its surrounding structures. The epidemiology …

Background The rapid increase in mobile telephone use has generated concern about
possible health risks related to radiofrequency electromagnetic fields from this technology …

The median survival of glioblastoma patients is∼ 12 months. However, 3–5% of the patients
survives for more than 3 years and are referred to as long-term survivors. The clinical and …

Simple Summary Glioblastoma multiforme (GBM) are among the most lethal tumors. The
highly invasive nature and presence of GBM stem cells, as well as the blood brain barrier …

Background There is no community standard for the treatment of glioblastoma in patients 70
years of age or older. We conducted a randomized trial that compared radiotherapy and …